Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 2, 2022
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
[ Wed, Mar 02nd 2022
] - WOPRAI
Jason Wittes Downgraded (ZBH) to Hold and Held Target at $130 on, Mar 2nd, 2022
Jason Wittes of Loop Capital, Downgraded "Zimmer Biomet Holdings, Inc." (ZBH) to Hold and Held Target at $130 on, Mar 2nd, 2022.
Jason has made no other calls on ZBH in the last 4 months.
There are 17 other peers that have a rating on ZBH. Out of the 17 peers that are also analyzing ZBH, 9 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Kyle Rose of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $125 on, Tuesday, February 8th, 2022
- Pito Chickering of "Deutsche Bank" Maintained at Hold with Decreased Target to $121 on, Tuesday, February 8th, 2022
- Shagun Singh of "RBC Capital" Maintained at Hold with Decreased Target to $125 on, Tuesday, February 8th, 2022
- Matthew O'Brien of "Piper Sandler" Maintained at Hold with Decreased Target to $110 on, Monday, February 7th, 2022
- Matthew Taylor of "UBS" Downgraded from Strong Buy to Hold and Decreased Target to $130 on, Wednesday, February 2nd, 2022
- Ryan Zimmerman of "BTIG" Downgraded from Strong Buy to Hold on, Monday, January 10th, 2022
- Cecilia Furlong of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $145 on, Friday, January 7th, 2022
- Matt O'Brien of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $135 on, Tuesday, January 4th, 2022
- David Toung of "Argus Research" Downgraded from Strong Buy to Hold on, Tuesday, November 23rd, 2021
These are the ratings of the 8 analyists that currently disagree with Jason
- Danielle Antalffy of "SVB Leerink" Maintained at Buy with Decreased Target to $135 on, Tuesday, February 8th, 2022
- David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $145 on, Tuesday, February 8th, 2022
- Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $129 on, Tuesday, February 8th, 2022
- Lawrence Biegelsen of "Wells Fargo" Maintained at Sell with Decreased Target to $111 on, Tuesday, February 8th, 2022
- Mike Matson of "Needham" Maintained at Strong Buy with Decreased Target to $143 on, Tuesday, February 8th, 2022
- Richard Newitter of "Truist Securities" Maintained at Strong Buy with Decreased Target to $128 on, Tuesday, February 8th, 2022
- Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Sell and Decreased Target to $124 on, Wednesday, January 19th, 2022
- Anthony Petrone of "Jefferies" Maintained at Strong Buy with Decreased Target to $175 on, Friday, November 5th, 2021
